{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T13:29:33Z","timestamp":1764077373595,"version":"3.41.2"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T00:00:00Z","timestamp":1655683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004156","name":"Mahidol University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","award":["X\/013296","X\/167000"],"award-info":[{"award-number":["X\/013296","X\/167000"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oral. Health"],"abstract":"<jats:p>Medication-related osteonecrosis of the jaw (MRONJ) is an often-severe complication found in patients receiving bisphosphonates in the management of Paget's, osteoporosis and metastatic bone cancer. Mucosal breakdown with bone exposure is a primary clinical presentation of MRONJ linked to the inhibitory effect of nitrogen-containing bisphosphonates (N-BP) on the mevalonate pathway. Geranylgeraniol (GGOH) has demonstrated a rescue effect on N-BP-treated osteoclasts but the biological effects on oral soft tissues and cells remain unclear. This study aimed to determine whether GGOH could prevent bisphosphonate induced toxicity to oral mucosa cells <jats:italic>in vitro<\/jats:italic>. Primary oral fibroblasts and keratinocytes were exposed to different GGOH concentrations or GGOH in combination with two nitrogen-containing bisphosphonates, zoledronic acid (ZA) or pamidronic acid (PA), for 72 h. The metabolic activity of each cell type was measured using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. GGOH without bisphosphonates significantly reduced the metabolic activity of oral mucosa cells. Fibroblasts treated with GGOH and ZA in combination showed a slight increase in metabolic status compared to fibroblasts treated with ZA alone, however this positive effect was not observed in keratinocytes. In the presence of PA, GGOH was unable to increase the metabolic activity of either cell type. These findings demonstrate that GGOH is toxic to oral mucosa cells and that GGOH was not able to prevent bisphosphonate induced toxicity. These data show that GGOH does not have therapeutic potential for bisphosphonate-induced soft tissue toxicity in MRONJ and the use of GGOH as an MRONJ treatment should be strongly reconsidered.<\/jats:p>","DOI":"10.3389\/froh.2022.892615","type":"journal-article","created":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T05:40:28Z","timestamp":1655703628000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["In vitro Effect of Geranylgeraniol (GGOH) on Bisphosphonate-Induced Cytotoxicity of Oral Mucosa Cells"],"prefix":"10.3389","volume":"3","author":[{"given":"Krit","family":"Rattanawonsakul","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Bullock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Bolt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederik","family":"Claeyssens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Atkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Hearnden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1111\/jop.12181","article-title":"Zoledronic acid and geranylgeraniol regulate cellular behaviour and angiogenic gene expression in human gingival fibroblasts","volume":"43","author":"Zafar","year":"2014","journal-title":"J Oral Pathol Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"4351327","DOI":"10.1155\/2019\/4351327","article-title":"Geranylgeraniol (GGOH) as a mevalonate pathway activator in the rescue of bone cells treated with zoledronic acid: an in vitro study","volume":"2019","author":"Fliefel","year":"2019","journal-title":"Stem Cells Int."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1016\/j.joms.2011.03.005","article-title":"Novel therapy to reverse the cellular effects of bisphosphonates on primary human oral fibroblasts","volume":"69","author":"Cozin","year":"2011","journal-title":"J Oral Maxillofac Surg."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw-\u22122014 update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J Oral Maxillofac Surg."},{"key":"B5","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1634\/theoncologist.2010-0183","article-title":"Quality of life implications of bisphosphonate-associated osteonecrosis of the jaw","volume":"16","author":"Miksad","year":"2011","journal-title":"Oncologist."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J Oral Maxillofac Surg."},{"key":"B7","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.joms.2022.02.008","article-title":"American Association of Oral and Maxillofacial Surgeons' Position Paper on Medication-Related Osteonecrosis of the Jaw \u2013 2022 Update","volume":"80","author":"Ruggiero","year":"2022","journal-title":"J Oral Maxillofac Surg"},{"key":"B8","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.bone.2007.04.196","article-title":"Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity?","volume":"41","author":"Reid","year":"2007","journal-title":"Bone."},{"key":"B9","doi-asserted-by":"publisher","first-page":"822411","DOI":"10.3389\/froh.2021.822411","article-title":"A review into the effects of pamidronic acid and zoledronic acid on the oral mucosa in medication-related osteonecrosis of the jaw","volume":"2","author":"Bullock","year":"2022","journal-title":"Front Oral Heal"},{"key":"B10","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1755-1536-3-6","volume":"3","author":"Scheper","year":"2010","journal-title":"Fibrogenes Tissue Repair."},{"key":"B11","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.archoralbio.2011.11.015","article-title":"Zoledronic Acid induces S-phase arrest via a DNA damage response in normal human oral keratinocytes","volume":"57","author":"Ohnuki","year":"2012","journal-title":"Arch Oral Biol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.joms.2008.01.026","article-title":"Inhibition of oral mucosal cell wound healing by bisphosphonates","volume":"66","author":"Landesberg","year":"2008","journal-title":"J Oral Maxillofac Surg."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1111\/odi.13160","article-title":"Workshop of European task force on medication-related osteonecrosis of the jaw-Current challenges","volume":"25","author":"Schiodt","year":"2019","journal-title":"Oral Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"97","DOI":"10.4103\/2231-0762.178742","article-title":"Medication-related osteonecrosis of the jaw: Clinical and practical guidelines","volume":"6","author":"Rosella","year":"2016","journal-title":"J Int Soc Prev Community Dent."},{"key":"B15","doi-asserted-by":"publisher","first-page":"680","DOI":"10.3390\/antiox10050680","article-title":"Various Therapeutic Methods for the Treatment of Medication-Related Osteonecrosis of the Jaw (MRONJ) and Their Limitations: A Narrative Review on New Molecular and Cellular Therapeutic Approaches","volume":"10","author":"Cho","year":"2021","journal-title":"Antioxidants"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1007\/s00784-014-1320-4","article-title":"Bisphosphonates inhibit cell functions of HUVECs, fibroblasts and osteogenic cells via inhibition of protein geranylgeranylation","volume":"19","author":"Hagelauer","year":"2015","journal-title":"Clin Oral Investig."},{"key":"B17","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.jcms.2017.11.007","article-title":"I effects of geranylgeraniol on the development of bisphosphonate-related osteonecrosis of the jaws","volume":"46","author":"Koneski","year":"2018","journal-title":"J Cranio-Maxillo-Facial Surg."},{"key":"B18","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1007\/s12663-013-0564-x","article-title":"Bisphosphonate Related Osteonecrosis of the jaw: an update","volume":"13","author":"Kumar","year":"2014","journal-title":"J Maxillofac Oral Surg."},{"key":"B19","doi-asserted-by":"publisher","first-page":"202066","DOI":"10.1098\/rsos.202066","article-title":"Geranylgeraniol prevents zoledronic acid-mediated reduction of viable mesenchymal stem cells via induction of Rho-dependent YAP activation","volume":"8","author":"Singhatanadgit","year":"2021","journal-title":"R Soc Open Sci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.jcms.2015.03.014","article-title":"The influence of geranylgeraniol on human oral keratinocytes after bisphosphonate treatment: an in vitro study","volume":"43","author":"Pabst","year":"2015","journal-title":"J Craniomaxillofac Surg."},{"key":"B21","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.oraloncology.2010.12.003","article-title":"Geranylgeraniol \u2013 A new potential therapeutic approach to bisphosphonate associated osteonecrosis of the jaw","volume":"47","author":"Ziebart","year":"2011","journal-title":"Oral Oncol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1177\/0022034511402995","article-title":"Bisphosphonates induce senescence in normal human oral keratinocytes","volume":"90","author":"Kim","year":"2011","journal-title":"J Dent Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s00784-009-0365-2","article-title":"Bisphosphonates: restrictions for vasculogenesis and angiogenesis: inhibition of cell function of endothelial progenitor cells and mature endothelial cells in vitro","volume":"15","author":"Ziebart","year":"2011","journal-title":"Clin Oral Investig."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.3390\/ijms20092320","article-title":"Geranylgeraniol suppresses the expression of IRAK1 and TRAF6 to inhibit NFB activation in lipopolysaccharide-induced inflammatory responses in human macrophage-like cells","volume":"20","author":"Giriwono","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B25","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1080\/10412905.2010.9700321","article-title":"Antibacterial activities against staphylococcus aureus of terpene alcohols with aliphatic carbon chains","volume":"22","author":"Togashi","year":"2010","journal-title":"J Essent Oil Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1111\/j.1349-7006.2001.tb01181.x","article-title":"Geranylgeraniol, an intermediate product in mevalonate pathway, induces apoptotic cell death in human hepatoma cells: death receptor-independent activation of Caspase-8 with down-regulation of Bcl-xL Expression","volume":"92","author":"Takeda","year":"2001","journal-title":"Jpn J Cancer Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1177\/1535370213492693","article-title":"Geranylgeraniol suppresses the viability of human DU145 prostate carcinoma cells and the level of HMG CoA reductase","volume":"238","author":"Fernandes","year":"2013","journal-title":"Exp Biol Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.jss.2008.04.021","article-title":"Plaunotol and geranylgeraniol induce caspase-mediated apoptosis in colon cancer","volume":"153","author":"Yoshikawa","year":"2009","journal-title":"J Surg Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"6463807","DOI":"10.1155\/2018\/6463807","article-title":"Geranylgeraniol prevents statin-dependent myotoxicity in C2C12 muscle cells through RAP1 GTPase prenylation and cytoprotective autophagy","volume":"2018","author":"Ja\u015bkiewicz","year":"2018","journal-title":"Oxid Med Cell Longev."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1128\/MCB.20.4.1436-1447.2000","article-title":"Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics","volume":"20","author":"Dickson","year":"2000","journal-title":"Mol Cell Biol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.3390\/ma13092086","article-title":"Synthetic hydroxyapatite inhibits bisphosphonate toxicity to the oral mucosa in vitro","volume":"13","author":"Bullock","year":"2020","journal-title":"Mater"},{"key":"B32","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/wrr.12154","article-title":"The importance of both fibroblasts and keratinocytes in a bilayered living cellular construct used in wound healing","volume":"22","author":"Wojtowicz","year":"2014","journal-title":"Wound Repair Regen."},{"key":"B33","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13104-015-1000-8","article-title":"Limitations of the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay when compared to three commonly used cell enumeration assays","volume":"8","author":"Van Tonder","year":"2015","journal-title":"BMC Res Notes"},{"key":"B34","unstructured":"Geranylgeranylated proteins are involved in the regulation of myeloma cell growth\n            van de DonkNWCJ\n            LokhorstHM\n            NijhuisEHJ\n            KamphuisMMJ\n            BloemAC\n          15701825Clin Cancer Res.2005"}],"container-title":["Frontiers in Oral Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/froh.2022.892615\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T05:40:31Z","timestamp":1655703631000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/froh.2022.892615\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,20]]},"references-count":34,"alternative-id":["10.3389\/froh.2022.892615"],"URL":"https:\/\/doi.org\/10.3389\/froh.2022.892615","relation":{},"ISSN":["2673-4842"],"issn-type":[{"type":"electronic","value":"2673-4842"}],"subject":[],"published":{"date-parts":[[2022,6,20]]},"article-number":"892615"}}